Dtsch Med Wochenschr 2009; 134: S140-S143
DOI: 10.1055/s-0029-1222591
Kurzübersicht | Review article
Schlafmedizin, Schmerztherapie
© Georg Thieme Verlag KG Stuttgart · New York

Praxisorientierte Therapie von Schmerz und Schlafdefizit

Treatment of pain and sleep deficit in general practiceW. Schwarz1
  • 1St. Marianus – Zentrum für Schwerkranke, Bardowick
Further Information

Publication History

eingereicht: 11.11.2008

akzeptiert: 12.03.2009

Publication Date:
24 June 2009 (online)

Literatur

  • 1 Eriksen J, Sjögren P, Bruera E. et al . Critical issues on opioids in chronic non-cancer pain: an epidemiological study.  Pain. 2006;  125 172-179
  • 2 Freye E. Opioide in der Medizin. 6. Auflage,. 6. Auflage, Springer Verlag 2004 Kapitel 9.3: 67-70
  • 3 Freye E, Levy J V. Einsatz der Opioide bei alten Patienten: Pharmakokinetische und pharmakodynamische Überlegungen.  Anästhesiol Intensivmed Notfallmed Schmerzther. 2004;  39 527-537
  • 4 Hale M, Tudor I C, Khanna S, Thipphawong J. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.  Clin Ther. 2007;  29 874-888
  • 5 Kosinski M, Kavanagh S. Sleep outcomes for patients with osteoarthritis of the hip or knee: Evidence from a randomized controlled trial of once-daily OROS hydromorphone versus extended-release oxycodone.  J Pain. 2006;  7, Suppl S55
  • 6 Maier C. Auch Sucht ist eine Krankheit. Editorial.  Der Schmerz. 2008;  22 639-643
  • 7 Melzack R, Wall P D. Pain mechanism – a new theory.  Science. 1965;  150 971-979
  • 8 Miaskowski C. Pharmacologic management of sleep disturbances in noncancer-related pain.  Pain Management Nursing. 2009;  Vol. 10, Issue 1 3-13
  • 9 Sabatowski R, Giesecke T. Pharmacotherapy of chronic, non tumour-related pain. Efficacy, tolerability and patient benefit of an oral osmotic system with hydromorphone.  MMW Fortschr Med. 2007;  149 (Suppl 3) 119-124
  • 10 Turk D C, Dworkin R H, Revicki D. et al . Identifying important outcome domains for chronic pain clinical trials: An IMMPACT survey of people with pain.  Pain. 2008;  137 276-285
  • 11 Walker J M, Farney J R, Rhondeau S M. et al . Chronic opioid use is a risk factor in the development of central sleep apnea and ataxic breathing.  J Clin Sleep Med. 2007;  3 455-461
  • 12 Wallace M. et al . Efficacy and safety evaluation of once-daily OROS hydromorphone in patients with chronic low back pain: a pilot open-label study (DO-127).  Curr Med Res Opin. 2007;  23 981-989

Dr. Wolfgang Schwarz

Schlöpke Weg 8

21357 Bardowick

Phone: 04131/925150

Fax: 04131/9251525

Email: st.marianus@t.online.de

    >